Arcturus Therapeutics is developing portfolio of RNA therapeutics for treatment of diseases with high unmet medical needs. Our hope and vision is to build transformative, life-changing medicines for patients and their families.
Our team has extensive experience in the discovery and development of RNA medicines, as well as design and utilization of lipid-mediated drug delivery systems. This combination of in-house expertise, innovative spirit, and passion for what we do, uniquely positions us to catalyze the next generation of RNA medicines.
August 26, 2019
Arcturus Therapeutics To Present at Two Investor Conferences in September
August 15, 2019
Arcturus Therapeutics Announces Second Quarter Financial Results and Provides a Corporate Update
August 7, 2019
Arcturus to Report Corporate Overview and Financial Results on August 15